ArticleAnnals of clinical and translational neurology2017

A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III).

Kevin M Biglan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.